James Meservy
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Mitochondrial Function and Pathology 2
- DNA Repair Mechanisms 2
- Plant Reproductive Biology 1
-
- Genetic Neurodegenerative Diseases 2
- Hereditary Neurological Disorders 1
- Co-authors
- Yaroslav Ilnytskyy (1 shared paper)Volodymyr Tryndyak (1 shared paper)Jody Filkowski (1 shared paper)Olga Kovalchuk (1 shared paper)В Ф Чехун (1 shared paper)Igor P. Pogribny (1 shared paper)John H. Wilson (2 shared papers)Jessica Lee Erickson (1 shared paper)
- Journals
- Photochemistry and Photobiology (2 papers)Molecular and Cellular Biology (2 papers)Molecular Cancer Therapeutics (1 paper)The Plant Journal (1 paper)
- Partner nations
- United StatesCanadaUkraine
In The Last Decade
James Meservy
6 papers receiving 617 citations
James Meservy's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 403
- Molecular Biology 548
- Oncology 95
- Cellular and Molecular Neuroscience 55
- Toxicology 6
Countries citing papers authored by James Meservy
This map shows the geographic impact of James Meservy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Meservy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Meservy more than expected).
Fields of papers citing papers by James Meservy
This network shows the impact of papers produced by James Meservy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Meservy. The network helps show where James Meservy may publish in the future.
Co-authors
The 25 scholars most cited alongside James Meservy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Hit paper breakdown → | 2008 | 522 |
| 2 | 2003 | 36 | |
| 3 | 2010 | 31 | |
| 4 | 2003 | 31 | |
| 5 | 1999 | 4 | |
| 6 | 1999 | 2 |
About James Meservy
James Meservy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Cancer Research, Pathology and Forensic Medicine and Biotechnology, having authored 6 papers that have together received 626 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (2 papers), Mitochondrial Function and Pathology (2 papers), DNA Repair Mechanisms (2 papers), MicroRNA in disease regulation (1 paper), Plant Molecular Biology Research (1 paper), Hereditary Neurological Disorders (1 paper), Cancer-related molecular mechanisms research (1 paper) and Plant Reproductive Biology (1 paper). The work is most often cited by research in Cancer Research (403 citations), Molecular Biology (548 citations), Oncology (95 citations), Cellular and Molecular Neuroscience (55 citations) and Toxicology (6 citations). James Meservy has collaborated with scholars based in United States, Canada and Ukraine. Frequent co-authors include Yaroslav Ilnytskyy, Volodymyr Tryndyak, Jody Filkowski, Olga Kovalchuk, В Ф Чехун, Igor P. Pogribny, John H. Wilson, Jessica Lee Erickson, Elizabeth Schultz and Hong‐Wei Hou. Their work appears in journals such as Photochemistry and Photobiology, Molecular and Cellular Biology, Molecular Cancer Therapeutics and The Plant Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.